Protocol for a randomised pragmatic policy trial of nicotine products for quitting or long-term substitution in smokers

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Fraser, Doug ^a   Borland, Ron ^b,c   Gartner, Coral ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

E cigarettes; Harm reduction; Nicotine; Pragmatic trial; Randomized controlled trial; Smoking

Indexed keywords

NICOTINE; NICOTINE GUM;

AUSTRALIA; CONTROLLED STUDY; ELECTRONIC CIGARETTE; HUMAN; METHODOLOGY; NEW ZEALAND; POLICY; PROCEDURES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SMOKING CESSATION;

AUSTRALIA; ELECTRONIC CIGARETTES; HUMANS; NEW ZEALAND; NICOTINE; POLICY; RESEARCH DESIGN; SAMPLE SIZE; SMOKING CESSATION; SURVEYS AND QUESTIONNAIRES; TOBACCO USE CESSATION PRODUCTS;

EID: 84943278166     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-2366-1     Document Type: Article

References (26)

1. Begg SJ, Vos T, Barker B, Stanley L, Lopez AD. Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors. Med J Aust. 2008;188(1):36.
2. Gartner CE, Barendregt JJ, Hall WD. Predicting the future prevalence of cigarette smoking in Australia: how low can we go and by when? Tob Control. 2009;18(3):183-9.
3. Gilmore AB, Britton J, Arnott D, Ashcroft R, Jarvis MJ. The place for harm reduction and product regulation in UK tobacco control policy. J Public Health. 2009;31(1):3-10.
4. Tobacco Working Group. Technical report no. 2. Tobacco control in Australia: making smoking history. Canberra: National Preventative Health Taskforce; 2008.
5. Royal College of Physicians. Harm reduction in nicotine addiction: helping people who can't quit. London: Tobacco Advisory Group of the Royal College of Physicians; 2007.
6. Gartner CE, Hall WD, Vos T, Bertram MY, Wallace AL, Lim SS. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet. 2007;369(9578):2010-4.
7. Kozlowski LT, Strasser AA, Giovino GA, Erickson PA, Terza JV. Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction. Tob Control. 2001;10(3):201-3. doi: 10.1136/Tc.10.3.201.
8. Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res. 2014;20(5):218-25. doi: 10.1159/000360220.
9. Gartner CE, Hall WD. Should Australia lift its ban on low nitrosamine smokeless tobacco products? Med J Aust. 2008;188(1):44.
10. Kozlowski LT, Edwards BQ. "Not safe" is not enough: smokers have a right to know more than there is no safe tobacco product. Tob Control. 2005;14:ii3-7. doi: 10.1136/tc.2004.008334.
11. Kozlowski LT, O'Connor R, Edwards BQ. Some practical points on harm reduction: what to tell your lawmaker and what to tell your brother about Swedish snus. Tob Control. 2003;12(4):372-3.
12. Commonwealth of Australia. National Tobacco Strategy 2012-2018: a strategy to improve the health of all Australians by reducing the prevalence of smoking and its associated health, social and economic costs, and the inequalities it causes. Canberra: Commonwealth of Australia; 2012.
13. National Institute for Health and Care Excellence. Tobacco: harm-reduction approaches to smoking. London: National Institute for Health and Care Excellence; 2013.
14. Australian Government Department of Health, Therapeutic Goods Administration. The poisons standard (the SUSMP). Canberra: Commonwealth of Australia; 2015.
15. Stead L, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane DB Syst Rev. 2012;11:CD000146.
16. Douglas H, Hall W, Gartner C. E-cigarettes and the law in Australia. Aust Fam Physician. 2015;44(6):415-8.
17. Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction. 2014;109(9):1531-40. doi: 10.1111/add.12623.
18. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation: tool results from an online survey. Am J Prev Med. 2011;40(4):472-5. doi: 10.1016/j.amepre.2010.12.006.
19. Action on Smoking and Health. Use of electronic cigarettes (vapourisers) among adults in Great Britain. London: ASH; 2014.
20. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382:1629-37.
21. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane DB Syst Rev. 2014. doi: 10.1002/14651858.CD010216.pub2.
22. Hyland A, Laux FL, Higbee C, Hastings G, Ross H, Chaloupka F, et al. Cigarette purchase patterns in four countries and the relationship with cessation: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15 Suppl 3:iii59-64.
23. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791-9.
24. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319:670-4.
25. Australian Institute of Health and Welfare. 2013 National Drug Strategy Household Survey: detailed findings. Canberra: AIHW; 2014.
26. Yingst JM, Veldheer S, Hrabovsky S, Nichols TT, Wilson SJ, Foulds J. Factors associated with electronic cigarette users' device preferences and transition from first generation to advanced generation devices. Nicotine Tob Res. 2015. doi: 10.1093/ntr/ntv052.